-
1
-
-
49649104978
-
Mechanisms of chemoresistance to alkylating agents in malignant glioma
-
Sarkaria JN, et al. (2008) Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 14(10): 2900-2908.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.10
, pp. 2900-2908
-
-
Sarkaria, J.N.1
-
2
-
-
84859847164
-
Emerging insights into the molecular and cellular basis of glioblastoma
-
Dunn GP, et al. (2012) Emerging insights into the molecular and cellular basis of glioblastoma. Genes Dev 26(8): 756-784.
-
(2012)
Genes Dev
, vol.26
, Issue.8
, pp. 756-784
-
-
Dunn, G.P.1
-
3
-
-
65649115060
-
Hypoxia helps glioma to fight therapy
-
Amberger-Murphy V (2009) Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets 9(3): 381-390.
-
(2009)
Curr Cancer Drug Targets
, vol.9
, Issue.3
, pp. 381-390
-
-
Amberger-Murphy, V.1
-
4
-
-
0036359548
-
Hypoxia-A key regulatory factor in tumour growth
-
Harris AL (2002) Hypoxia-A key regulatory factor in tumour growth. Nat Rev Cancer 2(1): 38-47.
-
(2002)
Nat Rev Cancer
, vol.2
, Issue.1
, pp. 38-47
-
-
Harris, A.L.1
-
5
-
-
19944422751
-
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases
-
Winkler F, et al. (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6(6): 553-563.
-
(2004)
Cancer Cell
, vol.6
, Issue.6
, pp. 553-563
-
-
Winkler, F.1
-
6
-
-
0036703627
-
Hypoxic neuroprotection requires sequential activation of vascular endothelial growth factor receptor and Akt
-
Wick A, et al. (2002) Hypoxic neuroprotection requires sequential activation of vascular endothelial growth factor receptor and Akt. J Neurosci 22: 6401-6407.
-
(2002)
J Neurosci
, vol.22
, pp. 6401-6407
-
-
Wick, A.1
-
7
-
-
75149165633
-
Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors
-
Henze AT, et al. (2010) Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors. Cancer Res 70(1): 357-366.
-
(2010)
Cancer Res
, vol.70
, Issue.1
, pp. 357-366
-
-
Henze, A.T.1
-
8
-
-
0033984256
-
Carcinogenic nickel induces genes involved with hypoxic stress
-
Salnikow K, Blagosklonny MV, Ryan H, Johnson R, Costa M (2000) Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res 60(1): 38-41.
-
(2000)
Cancer Res
, vol.60
, Issue.1
, pp. 38-41
-
-
Salnikow, K.1
Blagosklonny, M.V.2
Ryan, H.3
Johnson, R.4
Costa, M.5
-
9
-
-
78649813933
-
The N-myc downstream regulated gene (NDRG) family: Diverse functions, multiple applications
-
Melotte V, et al. (2010) The N-myc downstream regulated gene (NDRG) family: diverse functions, multiple applications. FASEB J 24(11): 4153-4166.
-
(2010)
FASEB J
, vol.24
, Issue.11
, pp. 4153-4166
-
-
Melotte, V.1
-
10
-
-
68949093646
-
Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients
-
Sun B, et al. (2009) Decreased expression of NDRG1 in glioma is related to tumor progression and survival of patients. J Neurooncol 94(2): 213-219.
-
(2009)
J Neurooncol
, vol.94
, Issue.2
, pp. 213-219
-
-
Sun, B.1
-
11
-
-
0036726313
-
Stable suppression of tumorigenicity by virus-mediated RNA interference
-
Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2(3): 243-247.
-
(2002)
Cancer Cell
, vol.2
, Issue.3
, pp. 243-247
-
-
Brummelkamp, T.R.1
Bernards, R.2
Agami, R.3
-
12
-
-
84874739414
-
Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment
-
Weiler M, et al. (2013) Suppression of proinvasive RGS4 by mTOR inhibition optimizes glioma treatment. Oncogene 32(9): 1099-1109.
-
(2013)
Oncogene
, vol.32
, Issue.9
, pp. 1099-1109
-
-
Weiler, M.1
-
13
-
-
77952571590
-
Phase II trial of radiochemotherapy with daily concomitant and adjuvant intensified (one week on / one week off) TMZ plus indomethacin in newly diagnosed glioblastoma: UKT-05
-
Weiler M, et al. (2010) Phase II trial of radiochemotherapy with daily concomitant and adjuvant intensified (one week on / one week off) TMZ plus indomethacin in newly diagnosed glioblastoma: UKT-05. Int J Rad Biol Phys 77(3): 670-676.
-
(2010)
Int J Rad Biol Phys
, vol.77
, Issue.3
, pp. 670-676
-
-
Weiler, M.1
-
14
-
-
73349134695
-
NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide
-
Wick W, et al. (2009) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35): 5874-5880.
-
(2009)
J Clin Oncol
, vol.27
, Issue.35
, pp. 5874-5880
-
-
Wick, W.1
-
15
-
-
84863091424
-
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: The NOA-08 randomised, phase 3 trial
-
NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society
-
Wick W, et al.; NOA-08 Study Group of Neuro-oncology Working Group (NOA) of German Cancer Society (2012) Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: The NOA-08 randomised, phase 3 trial. Lancet Oncol 13(7): 707-715.
-
(2012)
Lancet Oncol
, vol.13
, Issue.7
, pp. 707-715
-
-
Wick, W.1
-
16
-
-
35148883007
-
Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter
-
Zhang P, Tchou-Wong KM, Costa M (2007) Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res 67(19): 9125-9133.
-
(2007)
Cancer Res
, vol.67
, Issue.19
, pp. 9125-9133
-
-
Zhang, P.1
Tchou-Wong, K.M.2
Costa, M.3
-
17
-
-
84862124600
-
NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer
-
Azuma K, et al. (2012) NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer. J Thorac Oncol 7(5): 779-789.
-
(2012)
J Thorac Oncol
, vol.7
, Issue.5
, pp. 779-789
-
-
Azuma, K.1
-
18
-
-
58649092475
-
MTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1)
-
García-Martínez JM, Alessi DR (2008) mTOR complex 2 (mTORC2) controls hydrophobic motif phosphorylation and activation of serum- and glucocorticoid-induced protein kinase 1 (SGK1). Biochem J 416(3): 375-385.
-
(2008)
Biochem J
, vol.416
, Issue.3
, pp. 375-385
-
-
García-Martínez, J.M.1
Alessi, D.R.2
-
19
-
-
77952745809
-
Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43- dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells
-
Murakami Y, et al. (2010) Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43- dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. Biochem Biophys Res Commun 396(2): 376-381.
-
(2010)
Biochem Biophys Res Commun
, vol.396
, Issue.2
, pp. 376-381
-
-
Murakami, Y.1
-
20
-
-
20044372154
-
MGMT gene silencing and benefit from temozolomide in glioblastoma
-
Hegi ME, et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10): 997-1003.
-
(2005)
N Engl J Med
, vol.352
, Issue.10
, pp. 997-1003
-
-
Hegi, M.E.1
-
21
-
-
84860816141
-
Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance
-
Tanaka K, et al. (2011) Oncogenic EGFR signaling activates an mTORC2-NF-κB pathway that promotes chemotherapy resistance. Cancer Discov 1(6): 524-538.
-
(2011)
Cancer Discov
, vol.1
, Issue.6
, pp. 524-538
-
-
Tanaka, K.1
-
22
-
-
58049216350
-
Differential dependence of hypoxia- inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2
-
Toschi A, Lee E, Gadir N, Ohh M, Foster DA (2008) Differential dependence of hypoxia- inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2. J Biol Chem 283(50): 34495-34499.
-
(2008)
J Biol Chem
, vol.283
, Issue.50
, pp. 34495-34499
-
-
Toschi, A.1
Lee, E.2
Gadir, N.3
Ohh, M.4
Foster, D.A.5
-
23
-
-
0035907309
-
Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1
-
Mikosz CA, Brickley DR, Sharkey MS, Moran TW, Conzen SD (2001) Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1. J Biol Chem 276(20): 16649-16654.
-
(2001)
J Biol Chem
, vol.276
, Issue.20
, pp. 16649-16654
-
-
Mikosz, C.A.1
Brickley, D.R.2
Sharkey, M.S.3
Moran, T.W.4
Conzen, S.D.5
|